Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCL8 | P10145 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CDC25A | P30304 | 1/20 | 0.49 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.47 |
| ▸ | UGT1A9 | O60656 | 1/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.47 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.47 |
| ▸ | TTR | P02766 | 1/20 | 0.47 |
| ▸ | ALB | P02768 | 1/20 | 0.47 |
| ▸ | UGT1A6 | P19224 | 1/20 | 0.47 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29512015 | 1.00 | CXCL8 (0.54) | CXCL8MEN1KMT2ACDC25AROCK2 | |
| Ammonia Solution, Strong SCHEMBL23300490 | 0.98 | CXCL8 (0.53) | CXCL8MEN1KMT2ACDC25AROCK2 | |
| SCHEMBL28306745 | 0.98 | CXCL8 (0.53) | CXCL8MEN1KMT2ACDC25AROCK2 | |
| Cadaverine Tartrate SCHEMBL29131150 | 0.90 | CXCL8 (0.46) | CXCL8MEN1KMT2ACDC25AROCK2 | |
| SCHEMBL7362942 | 0.87 | CXCL8 (0.44) | CXCL8MEN1KMT2ACDC25AROCK2 | |
| SCHEMBL7854767 | 0.86 | HDAC1 (0.50) | CXCL8MEN1KMT2ACDC25AROCK2 | |
| SCHEMBL5692314 | 0.85 | PARP1 (0.51) | CXCL8MEN1KMT2ACDC25ARAB9A | |
| SCHEMBL5842471 | 0.85 | KMT2A (0.58) | CXCL8MEN1KMT2ANPC1RAB9A | |
| SCHEMBL29620332 | 0.84 | MEN1 (0.50) | CXCL8MEN1KMT2AROCK2NPC1 | |
| SCHEMBL28095642 | 0.83 | AGTR1 (0.65) | CXCL8MEN1KMT2ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 717 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010755-A | O-chlorophenylglycine production process | 九江中星医药化工有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-118936155-B | Heat exchange equipment applied to production of o-chlorophenylglycine | 黑龙江泰纳科技集团股份有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-222709597-U | Automatic change chlorobenzene glycine ether production flow and controlling means | 湖北阿泰克生物科技股份有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-222678054-U | O-chlorobenzene glycine preparation device | 抚顺友联科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119075979-A | Catalyst for hydrogenation of phenyl derivatives and preparation thereof | 厦门嘉氢科技有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-118936155-A | Heat exchange equipment applied to production of o-chlorophenylglycine | 黑龙江泰纳科技集团股份有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118359514-A | N-ester salicylamide compound and preparation method and application thereof | 湖南科技大学 | 2024-07-19 | — | — | CN | claimed |
| CN-118325877-A | Acylase mutant and application of chemical-enzymatic synthesis of clopidogrel | 浙江工业大学 | 2024-07-12 | — | — | CN | claimed |
| CN-117964029-B | Method for preparing p-chlorophenylglycine based on waste liquid generated in production of chlorfenapyr | 内蒙古莱科作物保护有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-118108672-A | O-chlorophenylglycine synthesis intermediate and detection method of o-chlorophenylglycine | 抚顺顺能化工有限公司 | 2024-05-31 | — | — | CN | claimed |
| WO-2005122379-A9 | ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY | UNIV CALIFORNIA (US) | 2006-03-09 | — | — | WO | claimed |
| US-20060019900-A1 | Alpha-4 beta-1 integrin ligands for imaging and therapy | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-01-26 | — | — | US | claimed |
| WO-2005122379-A2 | ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-12-22 | — | — | WO | claimed |
| US-20040176637-A1 | Process for preparation of 2-chlorophenylglycine derivatives and enantiomerically separation | ROBERT C. C. WU (TW) | 2004-09-09 | — | — | US | claimed |
| WO-1998039286-A1 | METHOD FOR OBTAINING α-AMINO ACID ENANTIOMERS AND INTERMEDIATE DIASTEREOISOMERIC SALTS | SANOFI (FR) | 1998-09-11 | — | — | WO | claimed |
| EP-0442585-B1 | Process for racemization of an optically active amino acid amide | DSM NV (NL) | 1994-07-20 | — | — | EP | claimed |
| EP-0256971-B1 | COLOUR RIBBON FOR DYE TRANSFER BY HEAT REACTION | SIEMENS AKTIENGESELLSCHAFT (DE) | 1990-05-02 | — | — | EP | claimed |
| US-4756633-A | Inking ribbon including a sublimable release layer for color transfer under the influence of heat | DREES FRIEDRICH WILHELM (DE) | 1988-07-12 | — | — | US | claimed |
| EP-0256971-A1 | Colour ribbon for dye transfer by heat reaction | SIEMENS AKTIENGESELLSCHAFT (DE) | 1988-02-24 | — | — | EP | claimed |
| US-4073687-A | PENICILLINS OR CEPHALOSPORINS | SHIONOGI & CO., LTD. (JA) | 1978-02-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176637-A1 | Process for preparation of 2-chlorophenylglycine derivatives and enantiomerically separation | SRM, CES2, UGT1A6 | CXCL8 4470/4885MEN1 4810/4885KMT2A 2170/4885 |
| US-20060019900-A1 | Alpha-4 beta-1 integrin ligands for imaging and therapy | ITGA4, ITGB4, ITGA1 | CXCL8 1830/4885MEN1 892/4885KMT2A 3460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.